XT Logo.png
Discover the BitBEDR(Bitcoin EDen Rich) Listing on XT.COM
January 30, 2024 08:26 ET | XT.com
Singapore, Jan. 30, 2024 (GLOBE NEWSWIRE) -- XT.COM, the world’s first socially infused trading platform, is thrilled to announce the listing of BitBEDR(Bitcoin EDen Rich) on its platform in the...
Net Asset Value
January 30, 2024 08:24 ET | Thames Ventures VCT 1 plc
THAMES VENTURES VCT 1 PLC LEI: 213800R88MRC4Y3OIW86 NAV ANNOUNCEMENT30 JANUARY 2024 In advance of the proposed allotment of shares under the dividend reinvestment scheme on 2 February 2024, the...
Business Awards UK Honours Innovators in the 2023 Cloud Computing Awards
January 30, 2024 08:18 ET | Business Awards UK
HALIFAX, UK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Business Awards UK is delighted to present the winners of the 2023 Cloud Computing Awards. These awards celebrate the companies and technology...
ibn.png
IBN Spotlights Astiva Health CEO Dr. Tri T. Nguyen on The Bell2Bell Podcast
January 30, 2024 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Jan. 30, 2024 (GLOBE NEWSWIRE) -- IBN, a multi-dimensional communications organization engaged in connecting public companies with the investment community, proudly announces the airing...
JnanaTherapeutics_Logo_FullColor_RGB.png
Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU
January 30, 2024 08:15 ET | Jnana Therapeutics, Inc.
Jnana Therapeutics announces positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with PKU.
market-digits.jpg
mRNA Vaccine Market projected to reach USD 23.9 Billion by 2030, growing at a CAGR of 9.6% during the forecast period of 2023-2030 - claims by MarketDigits in its recent study Richmond, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to a research report "mRNA Vaccine Market”, by Type (Self-Amplifying RNA Vaccines, Non-Replicating mRNA Vaccines, Others), Indication (HIV,...
image001.jpg
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 30, 2024 08:15 ET | Panbela Therapeutics, Inc.
MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...
shareholders foundation logo.jpg
Investors who lost money with The Lovesac Company (NASDAQ: LOVE) shares should contact the Shareholders Foundation in connection with pending Lawsuit
January 30, 2024 08:15 ET | Shareholders Foundation, Inc.
A lawsuit is pending for certain investors in shares of The Lovesac Company and NASDAQ: LOVE investors should contact the Shareholders Foundation, Inc.
logo.jpg
Ress Life Investment A/S announces capital increase
January 30, 2024 08:14 ET | Ress Life Investments A/S
Ress Life Investments A/SNybrogade 12,1203 Copenhagen KDenmarkCVR nr. 33593163www.resslifeinvestments.comTo: Nasdaq CopenhagenDate: 30 January 2024 Corporate Announcement 04/2024 Ress Life...
LEAPCHARGERLOGO.jpg
LeapCharger Finalizing EV Prototype Designs, First Cars Expected Soon
January 30, 2024 08:14 ET | LeapCharger Corporation
CARSON CITY, NV, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – LeapCharger Corporation (OTC: LCCN) ("LeapCharger” or the "Company"), an electric vehicle (EV) charging company with disruptive...